Search:

< Go Back

MedNet Appoints Clareece West As Chief Operating Officer
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
RVX-208 Reduces Major Adverse Cardiovascular Events (MACE) Significantly in Patients with Diabetes Mellitus English
Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects
Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures
Pelvalon Announces Results from the LIFE Pivotal Trial at the 2014 AUGS/IUGA Conference
Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome
Restrospective Analysis Finds MiMedx EpiFix® As Most Effective In Rapid Resolution Of Diabetic Foot Ulcers When Compared With Two Other Skin Substitutes
Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials
Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer
DripDrop Now Available At H-E-B
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices English
Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome
Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
Data from iPrEx Open-Label Extension (OLE) Demonstrate High Interest in PrEP, Longer-term Evidence of Safety and Efficacy, and No Sign of Increased Risk Behavior Among PrEP Users
International team sheds new light on biology underlying schizophrenia
US Patent Office Grants McCord Research Endothelial Cell Treatment Patent
Puregraft® Filtration for Autologous Fat Transfer Demonstrates Significantly Higher Long-Term Retention Compared to Centrifuged Controls
ADB International Group Inc. Announces Partnership with Austen BioInnovation Institute to Bring E-QURE BST™ Wound Healing Device to U.S. Market
Innocutis Introduces Sitavig® 50mg (ACYCLOVIR) Muco-Adhesive Buccal Tablet For Relief From Herpes Labialis (Cold Sores)
Maxwell Biotech Venture Fund's Portfolio Company MetaMax Announces Enrollment of First Patients in Phase 1/2a Clinical Trial of its Lead Anticancer Drug MM-D37K
Syneron Receives China CFDA Clearance for elure™ Advanced Skin Brightening Lotion
Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor English
Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers
Celsion Corporation Announces $1 Million NIH, NIBIB - Career Development Award Grant for Glioblastoma Research with ThermoDox® and HIFU
Expanding Orthopedics Inc. has obtained FDA Clearance for its FLXfit™, the world's first 3D expandable interbody cage
Braeburn Pharmaceuticals Enrolls First Patients In Late-Stage Clinical Study Of Probuphine® For Opioid Dependence
CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China
Sequenom Laboratories Expands International Noninvasive Prenatal Testing Services To Broader Population With VisibiliT™ Test
High-Viscosity Glass Ionomers May Be a Viable Alternative for Placing Tooth Restorations and Sealing Dental Pits and Fissures
Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Prana Alzheimer's disease Development Program update
aTyr, The Hong Kong University of Science and Technology, The Scripps Research Institute and Stanford University Join in the Discovery of a New Class of Human Proteins
Shire Reports Top-Line Results From Two Head-to-Head Studies Comparing Vyvanse® (lisdexamfetamine dimesylate), CII, With Concerta® (methylphenidate HCl), CII, in Adolescents with ADHD
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
$2.5 Million Grant Will Establish Patient-Centered Outcomes Research Training Program At Einstein And Montefiore
BiologicTx® Selected As The Specialty Pharmacy For Prospective, Global, Multi-Center, Observational Treatment Registry Study Of Intravenous Immunoglobulin Maintenance Therapy In Alloantibody Positive Renal Allograft Recipients
ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
Dipexium Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers
Dipexium Pharmaceuticals Announces Successful Completion of Phase 1 Skin Irritation Trial of Locilex®
Ruthigen Treats First Human Subjects In Clinical Trial For RUT58-60
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a)
Helsinn Group and Chugai Pharma Marketing Enter Into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) in the UK and Ireland and for Palonosetron Monotherapy in the UK
Alzheimer%s Disease Global Clinical Trials Review, H1, 2014 English
Phobia Global Clinical Trials Review, H1, 2014
TauRx Therapeutics Achieves Enrollment Target in the First of Its Two Phase III Clinical Trials of LMTX™ in Alzheimer's Disease
Silk Road Medical Completes Enrollment In The ROADSTER Clinical Trial For Carotid Artery Disease
Biotie Therapies Selects Bracket's CDR System™ for Phase 2 Trial of Treatment of Parkinson's Disease

< Prev Next >
PR Newswire - United Business Media